Our Team
Samit Shah MD, PhD
Koen Vanderschuren PhD
Koen Vanderschuren PhD
Founder
Dr. Shah is an Interventional Cardiologist and physician-scientist at the Yale School of Medicine, driving innovation in coronary physiology and ischemic heart disease. He leads national research initiatives, including the DISCOVER INOCA registry, and brings deep expertise in translating cutting-edge science into impactful clinical solutions.
Koen Vanderschuren PhD
Koen Vanderschuren PhD
Koen Vanderschuren PhD
Head of Operations
Dr. Vanderschuren earned his PhD in Molecular Biology from Yale, where he developed bioengineering strategies to optimize biologics. As a former Project Leader at BCG and current Blavatnik Fellow with Yale Ventures, he brings deep expertise in R&D strategy, manufacturing optimization, and commercial execution to drive Angiomedix’s operational growth.
Carolyn Mazure PhD
Koen Vanderschuren PhD
Alexandra Lansky MD
Advisor
Dr. Mazure is a leading expert in women’s health research and policy, serving as the inaugural Chair of the White House Initiative on Women’s Health Research. She founded Women’s Health Research at Yale, a nationally recognized center advancing interdisciplinary science and innovation, and brings decades of leadership experience in NIH-funded research and women's health innovation.
Alexandra Lansky MD
Koen Vanderschuren PhD
Alexandra Lansky MD
Advisor
Dr. Lansky is Professor of Medicine at Yale and a global leader in cardiovascular clinical research. She has directed over 500 landmark trials in interventional cardiology, authored more than 500 peer-reviewed publications, and shaped international guidelines. Her expertise in device evaluation and regulatory strategy brings unpar
Advisor
Dr. Lansky is Professor of Medicine at Yale and a global leader in cardiovascular clinical research. She has directed over 500 landmark trials in interventional cardiology, authored more than 500 peer-reviewed publications, and shaped international guidelines. Her expertise in device evaluation and regulatory strategy brings unparalleled insight to Angiomedix’s innovation and clinical development.
